As of April 29, 2025, Carisma Therapeutics (CARM) has a market cap of $8.491 million USD. According to our data, Carisma Therapeutics is ranked No.8874 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 29, 2025 | $8.49 M |
-51.46%
|
Dec 31, 2024 | $17.49 M |
-85.70%
|
Dec 29, 2023 | $0.12 B |
-75.27%
|
Dec 30, 2022 | $0.49 B |
-25.15%
|
Dec 31, 2021 | $0.66 B |
-39.63%
|
Dec 31, 2020 | $1.09 B |
29.81%
|
Dec 31, 2019 | $0.84 B |
-26.76%
|
Dec 31, 2018 | $1.15 B |
75.09%
|
Dec 29, 2017 | $0.66 B |
-57.54%
|
Dec 30, 2016 | $1.55 B |
-36.54%
|
Dec 31, 2015 | $2.44 B |
-74.66%
|
Dec 31, 2014 | $9.64 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Gilead Sciences
GILD
|
$132.39 B |
-0.001 M
|
![]() USA
|
![]() Novartis
NVS
|
$224.23 B |
0.160 B
|
![]() Switzerland
|
![]() Bristol-Myers Squibb
BMY
|
$98.62 B |
0.002 M
|
![]() USA
|
![]() Amgen
AMGN
|
$152.20 B |
0.126 B
|
![]() USA
|
![]() Pfizer
PFE
|
$130.73 B |
-0.001 M
|
![]() USA
|
![]() Merck
MRK
|
$212.01 B |
-0.001 M
|
![]() USA
|
![]() Johnson & Johnson
JNJ
|
$375.13 B |
0.006 M
|
![]() USA
|
![]() Regeneron Pharmaceuticals
REGN
|
$62.20 B |
1.034 B
|
![]() USA
|
![]() Biogen
BIIB
|
$17.59 B |
0.000 M
|
![]() USA
|
![]() Moderna
MRNA
|
$10.76 B |
0.000 M
|
![]() USA
|
![]() BioNTech
BNTX
|
$25.00 B |
0.001 M
|
![]() Germany
|
![]() Sanofi
SNY
|
$128.86 B |
0.003 M
|
![]() France
|
![]() AstraZeneca
AZN
|
$222.30 B |
0.004 M
|
![]() UK
|
Market Cap | = | CARM Stock Price | * | CARM Shares Outstanding |
= | $0.20 | * | 41.79 M | |
= | $8.49 M |